Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP)
Phase 2 Unknown
132 enrolled
CHANCES
Phase 1 Unknown
27 enrolled
PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery
Phase 2/3 Unknown
1,194 enrolled 25 charts
DEBIRI
Phase NA Unknown
39 enrolled
Durvalumab and Lenvatinib With or Without Chemotherapy in First-Line Treatment of Advanced Biliary Tract Cancer
Phase 2 Unknown
40 enrolled
IMPROVE
Phase 2 Unknown
80 enrolled
Predicting Biomarker of Gastric Cancer Chemotherapy Response
Unknown
800 enrolled
Surufatinib, Toripalimab and Chemotherapy in Second-line MT and MSS CRC
Phase 2 Unknown
61 enrolled
Induction Chemotherapy Followed by Short Course Radiotherapy in Rectal Cancer
Phase 2 Unknown
70 enrolled
Efficacy and Safety of Tirelizumab Plus Chemotherapy Versus Chemotherapy Alone in Patients With Lymph Node Positive Gastric Cancer After Surgery
Phase 2 Unknown
60 enrolled
An Exploratory Study of Immunotherapy Combined With Anlotinib and Chemotherapy in Perioperative Treatment of LAGC
Phase NA Unknown
114 enrolled
Intraperitoneal Chemotherapy in Gastric Cancer With Peritoneal Carcinomatosis
Phase 2 Unknown
30 enrolled
COLT
Phase 2 Unknown
22 enrolled
Camrelizumab Combined With Neoadjuvant Concurrent Chemoradiotherapy for Resectable Locally Advanced ESCC(NICE-RT)
Phase 2 Unknown
50 enrolled
Neoadjuvant Treatment of Fruquintinib Combined With Concurrent Chemoradiotherapy for LARC
Phase 2 Unknown
40 enrolled
RECORD
Unknown
3,000 enrolled
Exploratory Study on Combined Conversion Immunotherapy for Liver Metastasis of MSS Type Initial Unresectable Colorectal Cancer Based on Gene Status
Phase 2/3 Unknown
40 enrolled
FOLRT
Phase 2 Unknown
50 enrolled
ICTCPTLAGC
Phase NA Unknown
57 enrolled
The Effect of Unfavorable Histological Features on the Oncological Outcomes of Colon Cancer
Unknown
1,367 enrolled
Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases
Unknown
200 enrolled
Phase II/III Study to Assess the Efficacy of Neoadjuvant Consolidation Chemotherapy in Rectal Cancer Patients.
Phase 2/3 Unknown
338 enrolled
Study of HLX10, Trastuzumab and Chemotherapy in First-line Treatment of HER2-positive Recurrent/Metastatic Gastric Cancer
Phase 2 Unknown
40 enrolled
Envafolimab Combined With Endostar and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer
Phase 2 Unknown
20 enrolled
Observational Study to Evaluate the Use of Targeted Therapies in Metastatic Colorectal Cancer
Unknown
1,104 enrolled
Thalidomide Combined With Chemotherapy and Monotherapy for Maintenance Treatment for Her2-negative Advanced GC
Phase 1/2 Unknown
106 enrolled
Correlation Between the Efficacy of Neoadjuvant Chemotherapy Combined With Immunotherapy of Operable Thoracic Esophageal Squamous Cell Carcinoma and the Metabolites of Intestinal Flora
Phase NA Unknown
30 enrolled
A Multicenter, Randomized Controlled, Phase II Clinical Study of First-line Chemotherapy and Camrelizumab With or Without Radiotherapy in the Treatment of Oligometastatic Esophageal Cancer
Phase 2 Unknown
118 enrolled
Clinical Study of Camrelizumab Combined With SOX in the Adjuvant Treatment of Advanced Gastric Adenocarcinoma or Gastric Esophageal Junction Adenocarcinoma
Phase 2 Unknown
72 enrolled
Effectiveness of Neoadjuvant Chemotherapy Combined With PD-1 Monoclonal Antibody in the Treatment of Operable Esophageal Squamous Cell Carcinoma
Phase 2 Unknown
30 enrolled
NICCE
Unknown
46 enrolled
Probiotics Combined With Standard Chemotherapy Plus Targeted Therapy in Patients With Metastatic Colorectal Cancer
Phase NA Unknown
140 enrolled
Concurrent Chemoradiotherapy After Endoscopic Resection for Stage I Esophageal Carcinoma
Phase 2 Unknown
56 enrolled
PROTACT
Phase 2 Unknown
80 enrolled
CTC vs Radiography as the Evidence of Recurrence in Colorectal Cancer Patients
Phase 3 Unknown
100 enrolled
A Trial of Camrelizumab Combined With Microwave Ablation and Chemotherapy in the Treatment of Colorectal Cancer Liver Metastasis/Pulmonary Metastasis
Phase 2 Unknown
37 enrolled
HIPEC Combined With Camrelizumab, Paclitaxel and S-1 for Conversion Therapy in Patients With Advanced Gastric Cancer With Peritoneal Metastasis
Phase NA Unknown
46 enrolled
RCT of TAE Simultaneously Combined Thermal Ablation for Large Hepatocellular Carcinoma
Phase NA Unknown
410 enrolled
MELODIC
Phase NA Unknown
18 enrolled
Improving Food Pleasure and Intake of Oncology Patients Receiving Chemotherapy
Unknown
100 enrolled
EGFR Monoclonal Antibody for Advanced Gastric Cancer
Phase 2 Unknown
100 enrolled
Sintilimab Injection Combined With Concurrent CCRT in Locally Advanced Esophageal Squamous Cell Carcinoma
Phase 2 Unknown
53 enrolled
Cetuximab Re-challenge for Colorectal Cancer Liver Metastasis
Phase 3 Unknown
50 enrolled
ACCORD
Phase 2 Unknown
92 enrolled
Neoadjuvant Chemotherapy With PISOXO for Locally-invaded-gastric Cancer (LIGC)
Phase 1/2 Unknown
30 enrolled
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Locally Advanced Gastric Cancer
Phase 2 Unknown
100 enrolled
Study of SCT-I10A Combined SCT200 or SCT-I10A Combined SCT200 Plus Chemotherapy in ESCC and CRC
Phase 1 Unknown
60 enrolled
Short Course Radiotherapy, Unresectable Rectal Cancer, Liver Metastasis
Phase 2 Unknown
40 enrolled
Teripalimab Plus Chemotherapy in Local Advanced Esophageal Cancer
Phase 2 Unknown
30 enrolled
Short Course Radiotherapy Followed Intensive Chemotherapy With Delayed Surgery for Rectal Cancer With Synchronous Distant Metastasis
Phase 2 Unknown
39 enrolled